Filing Flows › Teva Pharmaceutical Industries (TEVA) › How it makes money
How Teva Pharmaceutical Industries (TEVA) makes money
Teva Pharmaceutical Industries (TEVA) made $4.4B of revenue in the third quarter 2026 (Q3 2026), -2% from a year earlier. Sale of goods brought in $3.7B (85%); Distribution brought in $421M (10%); Other brought in $184M (4%). Of every dollar of revenue, 56¢ was left as gross profit, 16¢ was left as operating profit, 5¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Sale of goods | $3.7B | 85.1% | +4% | -4% |
| Distribution | $421M | 9.6% | -3% | +4% |
| Other | $184M | 4.2% | +163% | +52% |
| Licensing arrangements | $49.0M | 1.1% | +32% | +7% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $4.4B | 100.0% |
| Cost of revenue | $2.0B | 44.5% |
| Gross profit | $2.4B | 55.5% |
| Operating expenses | $1.7B | 39.3% |
| Operating profit | $714M | 16.2% |
| Income tax | $66.0M | 1.5% |
| Net earnings | $234M | 5.3% |
| Operating cash flow | $241M | 5.5% |
| Free cash flow | $121M | 2.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $4.4B | -2% |
| Q2 2026 | $4.1B | -0.8% |
| Q1 2026 | $4.0B | +2% |
| Q4 2025 | $4.7B | +11% |
| Q3 2025 | $4.5B | +3% |
| Q2 2025 | $4.2B | +0.3% |
| Q1 2025 | $3.9B | +2% |
From Teva Pharmaceutical Industries' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Teva Pharmaceutical Industries make money?
Teva Pharmaceutical Industries (TEVA) made $4.4B of revenue in the third quarter 2026 (Q3 2026), -2% from a year earlier. Sale of goods brought in $3.7B (85%); Distribution brought in $421M (10%); Other brought in $184M (4%). Of every dollar of revenue, 56¢ was left as gross profit, 16¢ was left as operating profit, 5¢ was left as net earnings.
What is Teva Pharmaceutical Industries' biggest business?
Sale of goods: $3.7B in the third quarter 2026, 85% of revenue, -4% from a year earlier.
What is Teva Pharmaceutical Industries' profit margin?
Net earnings were $234M, 5.3% of revenue, in the third quarter 2026; the operating margin was 16.2%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.